Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Deferiprone DR tablets 1000 mg (Low dosage)
Deferiprone DR tablets 1000 mg (High dosage)
Locations
5
United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
New York Presbyterian Hospital/Weill Cornell Medical Center
New York, New York, United States
St.Paul's Hospital
Vancouver, British Columbia, Canada
National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital
Goudi, Athens, Greece
San Luigi Gonzaga University Hospital Reparto Microcitemie-Pediatria
Orbassano (TO), Regione Gonzole, Italy
Start Date
March 6, 2019
Primary Completion Date
December 4, 2019
Completion Date
December 19, 2019
Last Updated
July 16, 2021
Lead Sponsor
ApoPharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions